Related Experiment Video
Updated: May 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance
Kimberly A Couch1, Teresa Geide
1Kimberly A. Couch, Pharm.D., M.A., FIDSA, FASHP, is President, Infectious Diseases Pharmacy Associates, Stevensville, MD, and Clinical Pharmacist, Complete Rx, Seaford, DE. Teresa Geide, Pharm. D., BCPS, CGP, is Clinical Pharmacy Specialist, Infectious Diseases, Orlando Veterans Affairs Medical Center, Orlando, FL.
Abstract:
The incidence of MDRSP continues to increase, causing significant morbidity and mortality. Health care providers should seize the opportunity to promote the judicious use of antimicrobials and vaccinate patients with the pneumococcal vaccines as a means to lessen this significant health problem. Pharmacists are poised to play a key role in patient care by assessing for the need and administering vaccines in compliance with the current guidelines. A pharmacist should have a key role on the antimicrobial stewardship team.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Atypical Pneumonia

